Viropro, Inc. (VPRO)

[BeamMeUpScotty]

Read-this-post-and-decide-for-yourself-what-is-going-to-happen-here.

Royston in my view is taking his knowledge of his oncology speciality to the next level. He is turning this company into a biotechnology incubator.

See this earlier post of mine. They told us ecactly what they're going to do with the company quite a while ago. We didn't appreciate the significance. As always, I provide a link for you to independently verify the text. I just edit it a different way to let what they've written sink in as you read it more slowly.

Just been revisiting this press release. Now we can see its significance as to what they were saying:

http://finance.yahoo.com/news/dr-ivor-royston-oncologist-entrepreneur-140000578.html


Because Dr. Royston is a renowned expert in Immuno-Oncology therapies,

Viropro believes his value in helping exploit this product category could be significant,

especially in light of Viropro's previously announced intention to acquire NovaRx.

In addition Dr. Royston will support Viropro's ongoing pursuit of strategic partnerships

with pharmaceutical companies

and the acquisition of underappreciated assets.

He will also play a pivotal role in recruiting senior executives for Viropro. Viropro's Board of Directors was unanimous in its approval of this nomination.

The effort to recruit Dr. Royston was spearheaded by

Dr. Kenneth A. Sorensen,

a member of Viropro's Board of Directors, who also directed the process leading to the proposed acquisition of NovaRx.

"Dr. Royston's background is ideal both for Viropro's long term strategy of building a diversified portfolio of high value assets and the immediate task of completing the clinical development of the NovaRx cancer immunotherapy portfolio," said Dr. Sorensen.